Maximum benefit of chemotherapy for osteosarcoma achieved—what are the next steps?

Research output: Contribution to journalComment/debate

13 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1340-1342
Number of pages3
JournalThe lancet oncology
Volume17
Issue number10
DOIs
StatePublished - Oct 1 2016

Fingerprint

Osteosarcoma
Drug Therapy

ASJC Scopus subject areas

  • Oncology

Cite this

Maximum benefit of chemotherapy for osteosarcoma achieved—what are the next steps? / Kleinerman, Eugenie.

In: The lancet oncology, Vol. 17, No. 10, 01.10.2016, p. 1340-1342.

Research output: Contribution to journalComment/debate

@article{2399196ae83c4ac3ae4be0aab3fd9161,
title = "Maximum benefit of chemotherapy for osteosarcoma achieved—what are the next steps?",
author = "Eugenie Kleinerman",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/S1470-2045(16)30270-4",
language = "English (US)",
volume = "17",
pages = "1340--1342",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "10",

}

TY - JOUR

T1 - Maximum benefit of chemotherapy for osteosarcoma achieved—what are the next steps?

AU - Kleinerman, Eugenie

PY - 2016/10/1

Y1 - 2016/10/1

UR - http://www.scopus.com/inward/record.url?scp=84992336009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992336009&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(16)30270-4

DO - 10.1016/S1470-2045(16)30270-4

M3 - Comment/debate

C2 - 27569441

AN - SCOPUS:84992336009

VL - 17

SP - 1340

EP - 1342

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 10

ER -